Drug delivery through microencapsulation

• US 6,458,118 B1
• Filed: 02/23/2000
• Issued: 10/01/2002
• Est. Priority Date: 02/23/2000
• Status: Expired due to Fees

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Prentice, Thomas R., Heruth, Kenneth T., Lent, Mark S.
• Primary Examiner(s): Lazarus, Ira S.
• Assistant Examiner(s): NGUYEN, CAMTU TRAN
• Application Number:
  US09/511,438
• Time in Patent Office: 951 Days
• Field of Search: 604/890.1, 604/891.1, 604/892.1, 604/288.01, 604/288.02, 604/288.03, 604/288.04, 604/22, 604/500, 604/502
• US Class Current: 604/891.1
• CPC Class Codes: A61M 2202/06 Solids
• CPC Class Codes: A61M 2202/064 Powder
• CPC Class Codes: A61M 2205/3523 using telemetric means
• CPC Class Codes: A61M 2210/0693 Brain, cerebrum
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00

Abstract

An implantable drug delivery device comprising a microencapsulated drug contained within at least one capsule, a carrier fluid that will dissolve the drug when freed from the capsule, a drug releaser for freeing the microencapsulated drug from the capsule, a reservoir in which the carrier fluid dissolves the drug, and an electromechanical pump to convey the dissolved drug to a catheter, through which the drug is delivered to a target site within a patient.

Claims

1. An implantable drug delivery device comprising:

a microencapsulated drug contained within at least one capsule,

a carrier fluid that will dissolve the drug when freed from the capsule,

a drug releaser for freeing the microencapsulated drug from the capsule,

a reservoir in which the carrier fluid dissolves the drug, and

an electromechanical pump to convey the dissolved drug to a catheter, through which the drug is delivered.

2. The device of claim 1, wherein the drug releaser for freeing the microencapsulated drug from the capsule comprises an ultrasonic sound emitter that emits sufficient sound waves to break the capsule open.

3. The device of claim 1, wherein the drug releaser for freeing the microencapsulated drug from the capsule comprises a mechanical crushing or grinding device that exerts sufficient force to break the capsule open.

4. The device of claim 1, wherein the drug releaser for freeing the microencapsulated drug from the capsule comprises a chemical dissolving or chemical splitting apparatus to break the capsule open.

5. The device of claim 1, wherein the drug releaser for freeing the microencapsulated drug from the capsule comprises an electrical current emitter to potentiate a chemical reaction in the capsule sufficient to break the capsule open.

6. The device of claim 1, wherein the drug releaser for freeing the microencapsulated drug from the capsule comprises a heater that conveys sufficient heat to the capsule to break the capsule open.

7. The device of claim 1, wherein the drug releaser for freeing the microencapsulated drug from the capsule comprises a pressure device that exerts sufficient pressure on the capsule to break the capsule open.

8. The device of claim 1, wherein the device further has a sensor that senses the physiological conditions at a target site.

9. The device of claim 1, wherein the device is programmed for drug delivery to a target site.

10. The device of claim 1, wherein the device is programmed for drug delivery to a target site via telemetry.

11. The device of claim 8, wherein the device has an electrical control circuit that receives signals from the sensor and controls the drug releaser for freeing the microencapsulated drug from the capsule based on the sensor signals.

12. The device of claim 8, wherein the device has an electrical control circuit that receives signals from the sensor and controls the amount of the drug delivered based on the sensor signals.

13. The device of claim 8, wherein the device has a control drug releaser responsive to the sensor signal for regulating a therapeutic dosage of the drug to the target site.

14. The device of claim 1, wherein the device further has a premixing vessel that contains the microencapsulated drug which delivers the microencapsulated drug to the reservoir for mixing with the carrier fluid.

15. A method for drug delivery by an implantable electromechanical pump and a catheter having a discharge portion and having a proximal end coupled to said pump, said method comprising the steps of:

implanting said pump outside a patient site;

surgically implanting said catheter so that said discharge portion lies adjacent a predetermined infusion site in the patient;

supplying to a reservoir at least one capsule containing a drug;

supplying to the reservoir a carrier fluid capable of dissolving the drug;

breaking open the capsule so as to free the drug from the capsule;

dissolving the drug in the carrier fluid to form a mixture;

and pumping the mixture to and through the discharge portion of the catheter and to the infusion site.

16. The method of claim 15, wherein the step of breaking open the capsule so as to free the drug from the capsule comprises subjecting the capsule to sound waves sufficient to break open the capsule.

17. The method of claim 15, wherein the step of breaking open the capsule so as to free the drug from the capsule comprises subjecting the capsule to a mechanical force sufficient to break open the capsule.

18. The method of claim 15, wherein the step of breaking open the capsule so as to free the drug from the capsule comprises subjecting the capsule to a chemical sufficient to dissolve or split the capsule in a sufficient manner to break open the capsule.

19. The method of claim 15, wherein the step of breaking open the capsule so as to fee the drug from the capsule comprises subjecting the capsule to an electrical current to potentiate a chemical reaction in the capsule sufficient to break the capsule open.

20. The method of claim 15, wherein the step of breaking open the capsule so as to free the drug from the capsule comprises subjecting the capsule to heat sufficient to break the capsule open.

21. The method of claim 15, wherein the step of breaking open the capsule so as to free the drug from the capsule comprises subjecting the capsule to pressure sufficient to break the capsule open.

22. The method of claim 15, wherein the method has the further step of sensing a physiological condition at the infusion site.

23. The method of claim 15, wherein the method has the further step of sensing an amount of a substance related to a physiological condition at the infusion site.

24. The method of claim 22, wherein the method has the further step of controlling the amount of drug delivery to the infusion site based on the physiological condition sensed at the infusion site.

25. The method of claim 23, wherein the method has the further step of controlling the amount of drug delivery to the infusion site based on the amount of the substance sensed at the infusion site.

26. The method of claim 15, wherein the method has the further step of programming an electrical circuit to control the amount of drug delivery to the infusion site.

27. The method of claim 15, wherein the method has the further step of programming an electrical circuit via telemetry to control the amount of drug delivery to the infusion site.

28. The method of claim 15, having the additional step of removing capsules that have been broken open, and replenishing the reservoir with at least one new capsule containing a drug through a port in the reservoir.

29. The method of claim 15, having the additional step of controlling the delivery of the drug to the infusion site based on a measurement of the concentration of the drug within the carrier fluid.

30. The method of claim 15, having the additional steps of implanting in the patient a premixing vessel containing the capsulated drug, and supplying the capsulated drug to the reservoir from the premixing vessel.

31. An implantable reagent delivery and sensor device comprising:

a microencapsulated reagent contained within at least one capsule,

a sensor having a reservoir that contains the microencapsulated reagent,

a drug releaser for freeing the microencapsulated reagent from the capsule,

the freed reagent being capable of reacting with a first substance to produce a second substance that is directly proportional to the amount of the first substance, the sensor capable of measuring the amount of the second substance.

32. The implantable reagent delivery and sensor device of claim 31, wherein the reagent is an oxidase, the first substance is oxygen, and the second substance is glucose, and the sensor is a glucose sensor.

33. The implantable reagent delivery and sensor device of claim 31, further having a transfer port in the reservoir through which capsules that have been broken open can be removed from the reservoir and microencapsulated reagent can be supplied to the reservoir.

34. The implantable reagent delivery and sensor device of claim 31, wherein the device is electrically connected to an electrical circuit that controls a delivery of a drug to an infusion site based on the measurement of the second substance produced by the reaction of the first substance with the reagent.